Kintor Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	32.74	147.42	445.5	865.08	930.15
Short-Term Investments	-	1.27	12.56	11.88	126.58
Cash & Short-Term Investments	32.74	148.69	458.05	876.96	1,057
Cash Growth	-77.98%	-67.54%	-47.77%	-17.01%	-24.15%
Accounts Receivable	2.8	-	-	-	-
Other Receivables	-	15.65	6.48	-	-
Receivables	2.8	15.65	6.48	-	-
Inventory	12.09	2.22	-	603.5	351.36
Restricted Cash	2.03	0.43	0.43	5.64	1.66
Other Current Assets	5.6	4.75	7.6	21.77	116.15
Total Current Assets	55.25	171.73	472.56	1,508	1,526
Property, Plant & Equipment	158.02	174.23	221.84	282.48	262.3
Long-Term Investments	16.25	16.57	18	17.95	-
Other Intangible Assets	107.26	148.95	148.94	235.65	235.62
Other Long-Term Assets	4.03	3.65	7.9	11.2	44.17
Total Assets	340.81	515.13	869.23	2,055	2,068
Accounts Payable	32.12	40.96	81.6	180.4	172.96
Accrued Expenses	3.77	6.68	17.32	19.89	25.12
Short-Term Debt	65	14.38	20	40	-
Current Portion of Long-Term Debt	20	97.38	93.7	58.9	7.4
Current Portion of Leases	0.61	1.25	4.53	4.44	2.07
Other Current Liabilities	6.08	6.03	7.58	14.5	12.2
Total Current Liabilities	127.58	166.68	224.73	318.13	219.74
Long-Term Debt	-	20	133.4	177.6	147.5
Long-Term Leases	0.99	-	2.29	5.45	2.76
Long-Term Unearned Revenue	2.97	3.32	19.66	19.95	4.01
Long-Term Deferred Tax Liabilities	26.68	31.04	31.04	38.82	38.82
Total Liabilities	158.21	221.05	411.12	559.95	412.83
Common Stock	0.35	0.32	0.32	0.32	0.27
Additional Paid-In Capital	-	4,210	4,182	4,104	3,359
Retained Earnings	-	-3,940	-3,785	-2,724	-1,769
Comprehensive Income & Other	182.25	23.58	60.73	114.77	65.49
Shareholders' Equity	182.6	294.08	458.11	1,495	1,655
Total Liabilities & Equity	340.81	515.13	869.23	2,055	2,068
Total Debt	86.6	133.01	253.92	286.39	159.73
Net Cash (Debt)	-53.86	15.68	204.13	590.57	897
Net Cash Growth	-	-92.32%	-65.43%	-34.16%	-23.43%
Net Cash Per Share	-0.12	0.04	0.48	1.57	2.52
Filing Date Shares Outstanding	465.48	434.2	439.4	447.5	387.59
Total Common Shares Outstanding	465.48	434.2	439.4	447.5	387.59
Working Capital	-72.33	5.05	247.83	1,190	1,306
Book Value Per Share	0.39	0.68	1.04	3.34	4.27
Tangible Book Value	75.34	145.13	309.17	1,260	1,420
Tangible Book Value Per Share	0.16	0.33	0.70	2.81	3.66
Buildings	-	89.23	89.23	89.23	57.66
Machinery	-	58.91	58.7	58.24	46.78
Construction In Progress	-	109.24	109.24	105.66	125.74

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.